ProSomnus® Receives Additional U.S. Utility Patent Covering Iterative Titration Technology for Company’s Novel Precision Sleep Apnea Medical Devices
“Our patented iterative titration technology is a cornerstone of our differentiation," said Len Liptak, Co-Founder and Chief Executive Officer of ProSomnus.
- “Our patented iterative titration technology is a cornerstone of our differentiation," said Len Liptak, Co-Founder and Chief Executive Officer of ProSomnus.
- "Iterative titration enables the mechanism of action for our precision medicine approach to treating Obstructive Sleep Apnea.
- By eliminating the components used by dental product style devices, iterative titration allows ProSomnus devices to be smaller, stronger and made from Medical Grade Class VI materials, too.
- ProSomnus Precision OAT devices consist of maxillary and mandibular aligners that are precision-manufactured with twin-mated posts, and are digitally milled to be patient-specific.